Compare · GATX vs SRTA
GATX vs SRTA
Side-by-side comparison of GATX Corporation (GATX) and Strata Critical Medical Inc. (SRTA): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both GATX and SRTA operate in Transportation Services (Consumer Discretionary), so they compete in similar markets.
- GATX is the larger of the two at $6.39B, about 14.5x SRTA ($442.2M).
- Over the past year, GATX is up 13.8% and SRTA is up 23.4% - SRTA leads by 9.6 points.
- SRTA has been more active in the news (7 items in the past 4 weeks vs 4 for GATX).
- GATX has more recent analyst coverage (16 ratings vs 3 for SRTA).
PerformanceGATX+13.76%SRTA+23.37%
2025-07-11+0.00%2026-07-10
- Company
- GATX Corporation
- Strata Critical Medical Inc.
- Price
- $180.00+2.54%
- $5.12-0.19%
- Market cap
- $6.39B
- $442.2M
- 1M return
- +3.38%
- -8.41%
- 1Y return
- +13.76%
- +23.37%
- Industry
- Transportation Services
- Transportation Services
- Exchange
- NYSE
- NASDAQ
- IPO
- 2019
- News (4w)
- 4
- 7
- Recent ratings
- 16
- 3
GATX
GATX Corporation
GATX Corporation (NYSE: GATX) strives to be recognized as the finest railcar leasing company in the world by our customers, our shareholders, our employees and the communities where we operate. As the leading global railcar lessor, GATX has been providing quality railcars and services to its customers for more than 122 years. GATX has been headquartered in Chicago, Illinois since its founding in 1898.
Latest GATX
- Gatx Corporation Sets Date for 2026 Second-Quarter Earnings Release and Conference Call
- SEC Form 8-K filed by GATX Corporation
- SEC Form 11-K filed by GATX Corporation
- SEC Form 11-K filed by GATX Corporation
- GATX Corporation to Present at the Wells Fargo 16th Industrials and Materials Conference
- GATX Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation
- SEC Form S-8 filed by GATX Corporation
- SEC Form 10-Q filed by GATX Corporation
- GATX Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
- GATX Corporation Reports 2026 First-Quarter Results
Latest SRTA
- Amendment: SEC Form SCHEDULE 13G/A filed by Strata Critical Medical Inc.
- Strata Acquires Heart and Lung Transplant National Recovery Program, Expanding National Organ Recovery Platform
- Amendment: Co-CEO and CFO Heyburn William A. covered exercise/tax liability with 31,671 shares, decreasing direct ownership by 2% to 1,548,997 units (SEC Form 4) to satisfy tax liability
- Amendment: Co-CEO and General Counsel Tomkiel Melissa M. covered exercise/tax liability with 29,730 shares, decreasing direct ownership by 2% to 1,892,774 units (SEC Form 4) (for tax liability)
- Amendment: Chief Accounting Officer Cohen Amir covered exercise/tax liability with 4,655 shares, decreasing direct ownership by 3% to 146,608 units (SEC Form 4) to satisfy withholding tax
- Amendment: CEO, Logistics Wunsch Scott M covered exercise/tax liability with 5,550 shares, decreasing direct ownership by 0.88% to 625,574 units (SEC Form 4) to satisfy tax liability
- SEC Form SCHEDULE 13G filed by Strata Critical Medical Inc.
- Co-CEO and CFO Heyburn William A. sold $185,909 worth of shares (31,671 units at $5.87), decreasing direct ownership by 2% to 1,548,997 units (SEC Form 4) (for withholding tax)
- Co-CEO and General Counsel Tomkiel Melissa M. sold $174,515 worth of shares (29,730 units at $5.87), decreasing direct ownership by 2% to 1,892,774 units (SEC Form 4) (for withholding tax)
- Chief Accounting Officer Cohen Amir sold $27,325 worth of shares (4,655 units at $5.87), decreasing direct ownership by 3% to 146,608 units (SEC Form 4) (tax withholding)